March 8, 2024
MSD’s PD-1 inhibitor Keytruda (pembrolizumab) raked in the largest sales in the Japan pharma market in February, extending its winning streak of the title to fifth month, according to a monthly snapshot report released by Encise. Keytruda generated sales of...read more